Related Experiment Videos
Localized melioidosis in children in Thailand: treatment and long-term outcome
Pagakrong Lumbiganon1, Napaporn Chotechuangnirun, Pope Kosalaraksa
1Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. paglum@kku.ac.th
Abstract:
Melioidosis, an infection caused by Burkholderia pseudomallei, can present as severe septicemia or localized infection. Data on optimum antibiotic treatment regimen for localized melioidosis in children is limited. This is a report on localized melioidosis in children, regarding clinical presentation, treatment and the long-term outcomes. We reviewed 37 cases of localized melioidosis in children treated between 1994 and 2006 and followed up them prospectively until 1 October 2007. The two most common presentations were skin/soft tissue infections and suppurative parotitis. Oral eradication antibiotics after initial parenteral therapy included trimetroprim-sulfamethoxazole (10 patients) and trimetroprim-sulfamethoxazole in combination with doxycycline (four patients). Patients who did not get any parenteral antibiotics for B. pseudomallei were treated with oral trimetroprim-sulfamethoxazole (10 patients) and trimetroprim-sulfamethoxazole in combination with doxycycline (one patient). No adverse effects were reported. We were able to follow-up 32 patients, all recovered except one patient reported a history of possible relapse.
Insights
Localized melioidosis in children, caused by Burkholderia pseudomallei, often presents as skin infections or parotitis. Trimethoprim-sulfamethoxazole, with or without doxycycline, showed effective oral eradication with no adverse effects in this pediatric study.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Melioidosis, caused by Burkholderia pseudomallei, is a significant infection with varied presentations, including severe septicemia and localized forms.
- Optimal antibiotic regimens for localized pediatric melioidosis remain under-researched, highlighting a critical knowledge gap in pediatric infectious disease management.
Purpose of the Study:
- To investigate the clinical presentation, treatment strategies, and long-term outcomes of localized melioidosis in pediatric patients.
- To evaluate the efficacy and safety of oral antibiotic regimens for localized melioidosis in children.
Main Methods:
- A retrospective review of 37 pediatric cases of localized melioidosis treated between 1994 and 2006.
- Prospective follow-up of patients until October 2007 to assess treatment outcomes and long-term results.
Main Results:
- The most frequent clinical presentations were skin/soft tissue infections and suppurative parotitis.
- Oral antibiotic regimens, primarily trimethoprim-sulfamethoxazole alone or with doxycycline, were used for eradication after initial parenteral therapy or as primary treatment.
- No adverse effects were reported during the treatment period, and 31 out of 32 followed-up patients recovered fully, with one reporting a possible relapse.
Conclusions:
- Localized melioidosis in children commonly manifests as skin/soft tissue infections or suppurative parotitis.
- Trimethoprim-sulfamethoxazole, with or without doxycycline, appears to be an effective and safe oral eradication regimen for localized pediatric melioidosis.
- Further research into long-term outcomes and potential relapses is warranted for comprehensive management strategies.
Related Concept Videos
Rocky Mountain Spotted Fever
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Acute Pyelonephritis II: Diagnostic Studies and Management
Tonsillitis II: Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Antiprotozoal Agents